BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 20561442)

  • 1. [Effect of bortezomib on VEGF gene expression of endothelial cell line HMEC-1 and its possible mechanisms].
    Xue LX; Jiang M; Xie LQ; Ruan CG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):744-8. PubMed ID: 20561442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of the hypoxia-inducible factor-1 response in cervical carcinoma xenografts by proteasome inhibitors.
    Birle DC; Hedley DW
    Cancer Res; 2007 Feb; 67(4):1735-43. PubMed ID: 17308115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of bortezomib on migration of endothelial cells and angiogenesis].
    Xue LX; Jiang M; Xie LQ; Ruan CG
    Zhonghua Xue Ye Xue Za Zhi; 2010 Jun; 31(6):403-6. PubMed ID: 21122357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression patterns of the hypoxia-related genes osteopontin, CA9, erythropoietin, VEGF and HIF-1alpha in human glioma in vitro and in vivo.
    Said HM; Hagemann C; Staab A; Stojic J; Kühnel S; Vince GH; Flentje M; Roosen K; Vordermark D
    Radiother Oncol; 2007 Jun; 83(3):398-405. PubMed ID: 17524506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteasomal inhibition attenuates transcriptional activity of hypoxia-inducible factor 1 (HIF-1) via specific effect on the HIF-1alpha C-terminal activation domain.
    Kaluz S; Kaluzová M; Stanbridge EJ
    Mol Cell Biol; 2006 Aug; 26(15):5895-907. PubMed ID: 16847340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cisplatin and doxorubicin repress Vascular Endothelial Growth Factor expression and differentially down-regulate Hypoxia-inducible Factor I activity in human ovarian cancer cells.
    Duyndam MC; van Berkel MP; Dorsman JC; Rockx DA; Pinedo HM; Boven E
    Biochem Pharmacol; 2007 Jul; 74(2):191-201. PubMed ID: 17498666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overcoming evasive resistance from vascular endothelial growth factor a inhibition in sarcomas by genetic or pharmacologic targeting of hypoxia-inducible factor 1α.
    Kim YJ; Lee HJ; Kim TM; Eisinger-Mathason TS; Zhang AY; Schmidt B; Karl DL; Nakazawa MS; Park PJ; Simon MC; Yoon SS
    Int J Cancer; 2013 Jan; 132(1):29-41. PubMed ID: 22684860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of carbonic anhydrase and HIF-1α in Wilms tumours.
    Dungwa JV; Hunt LP; Ramani P
    BMC Cancer; 2011 Sep; 11():390. PubMed ID: 21910893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of carbonic anhydrase IX in craniopharyngiomas.
    Proescholdt M; Merrill M; Stoerr EM; Lohmeier A; Dietmaier W; Brawanski A
    J Neurosurg; 2011 Oct; 115(4):796-801. PubMed ID: 21761968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intermittent hypoxia induces proteasome-dependent down-regulation of estrogen receptor alpha in human breast carcinoma.
    Cooper C; Liu GY; Niu YL; Santos S; Murphy LC; Watson PH
    Clin Cancer Res; 2004 Dec; 10(24):8720-7. PubMed ID: 15623657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide expression analysis using microarray identified complex signaling pathways modulated by hypoxia in nasopharyngeal carcinoma.
    Sung FL; Hui EP; Tao Q; Li H; Tsui NB; Lo YM; Ma BB; To KF; Harris AL; Chan AT
    Cancer Lett; 2007 Aug; 253(1):74-88. PubMed ID: 17320280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival.
    Hui EP; Chan AT; Pezzella F; Turley H; To KF; Poon TC; Zee B; Mo F; Teo PM; Huang DP; Gatter KC; Johnson PJ; Harris AL
    Clin Cancer Res; 2002 Aug; 8(8):2595-604. PubMed ID: 12171890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Src induces expression of carbonic anhydrase IX via hypoxia-inducible factor 1.
    Takacova M; Holotnakova T; Barathova M; Pastorekova S; Kopacek J; Pastorek J
    Oncol Rep; 2010 Mar; 23(3):869-74. PubMed ID: 20127031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of vascular endothelial growth factor, hypoxia inducible factor 1alpha, and carbonic anhydrase IX in human tumours.
    Jubb AM; Pham TQ; Hanby AM; Frantz GD; Peale FV; Wu TD; Koeppen HW; Hillan KJ
    J Clin Pathol; 2004 May; 57(5):504-12. PubMed ID: 15113858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase II trial with pharmacodynamic endpoints of the proteasome inhibitor bortezomib in patients with metastatic colorectal cancer.
    Mackay H; Hedley D; Major P; Townsley C; Mackenzie M; Vincent M; Degendorfer P; Tsao MS; Nicklee T; Birle D; Wright J; Siu L; Moore M; Oza A
    Clin Cancer Res; 2005 Aug; 11(15):5526-33. PubMed ID: 16061869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical detection of osteopontin in advanced head-and-neck cancer: prognostic role and correlation with oxygen electrode measurements, hypoxia-inducible-factor-1alpha-related markers, and hemoglobin levels.
    Bache M; Reddemann R; Said HM; Holzhausen HJ; Taubert H; Becker A; Kuhnt T; Hänsgen G; Dunst J; Vordermark D
    Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1481-7. PubMed ID: 17056190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of hypoxia-inducible factor inhibitor on expression of HIF-1alpha and VEGF and induction of apoptosis in leukemic cell lines].
    Wang F; Chen BA; Cheng J; Xu WL; Wang XM; Ding JH; Gao C; Sun YY; Wang J; Zhao G; Bao W; Song HH; Gao F; Zhang W; Xia GH; Pei XP; Wu WW; Yin L; Shan XY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Feb; 18(1):74-8. PubMed ID: 20137122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia-inducible factor-1α mRNA: a new target for destabilization by tristetraprolin in endothelial cells.
    Chamboredon S; Ciais D; Desroches-Castan A; Savi P; Bono F; Feige JJ; Cherradi N
    Mol Biol Cell; 2011 Sep; 22(18):3366-78. PubMed ID: 21775632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of hypoxia-induced transcription in normoxia.
    Hägg M; Wennström S
    Exp Cell Res; 2005 May; 306(1):180-91. PubMed ID: 15878343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA damage is a prerequisite for p53-mediated proteasomal degradation of HIF-1alpha in hypoxic cells and downregulation of the hypoxia marker carbonic anhydrase IX.
    Kaluzová M; Kaluz S; Lerman MI; Stanbridge EJ
    Mol Cell Biol; 2004 Jul; 24(13):5757-66. PubMed ID: 15199132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.